CCS is actively monitoring and responding to the recommendations of the Public Health Agency of Canada regarding coronavirus disease (COVID-19).
Treatments for stage 2 nasopharyngeal cancer
The following are treatment options for stage 2 nasopharyngeal cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.
Chemoradiation
Chemoradiation is the main treatment for stage 2 nasopharyngeal cancer. In chemoradiation, chemotherapy is given during the same time period as radiation therapy. Each treatment makes the other more effective.
Chemoradiation therapy for stage 2 nasopharyngeal cancer uses cisplatin and external beam radiation therapy.
Radiation therapy
You may be offered radiation therapy for stage 2 nasopharyngeal cancer if you can’t tolerate chemoradiation and its side effects. External beam radiation is given to the site of the tumour followed by preventive radiation to the lymph nodes in the neck (cervical lymph nodes).
The type of external beam radiation therapy used for stage 2 nasopharyngeal cancer is usually intensity-modulated radiation therapy (IMRT).
Chemotherapy
Chemotherapy with cisplatin and 5-fluorouracil (Adrucil, 5-FU) is often given after radiation or chemoradiation therapy to lower the chance that the cancer will come back (recur).
Clinical trials
Talk to your doctor about clinical trials open to people with nasopharyngeal cancer in Canada. Clinical trials look at new ways to prevent, find and treat cancer. Find out more about clinical trials.
Together we can reduce the burden of cancer
Last year, we only had the resources available to fund 40% of high-priority research projects. Imagine the impact we could have if we were able to fund 100%.
